Daniel Durand-Herrera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel Durand-Herrera has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Fernando Campos
Tissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, 18016 Granada, Spain
10 shared publications - Víctor Carriel
Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
10 shared publications - Miguel Alaminos
Tissue Engineering Group, Department of Histology, University of Granada, Granada, Spain
9 shared publications - Antonio Campos
Tissue Engineering Group, Department of Histology, University of Granada and Instituto de Investigación Biosanitaria ibs.GRANADA, E18016 Granada, Spain
7 shared publications - Jesús Chato-Astrain
University of Granada
6 shared publications - Miguel Ángel Martín-Piedra
Tissue Engineering Group, Department of Histology, School of Medicine, University of Granada, E18016 Granada, Spain
5 shared publications
Latest Publications
- Open Access
- 8 May 2026
- Published by Royal Society of Chemistry (RSC) in Sensors & Diagnostics
- Vol. 5 (6) , 858-867
Establishment of a peptide-based electrochemical immunosensor for detecting antibodies against the GP5 protein from the porcine reproductive and respiratory syndrome virus
Porcine reproductive and respiratory syndrome (PRRS) is one of the most economically devastating diseases that affect the swine industry worldwide. Although enzyme-linked immunosorbent assays (ELISAs) are the gold standard for analyzing antibodies against viruses, they have some limitations, such as sample transport and analysis times and cost. Rapid serological surveillance of PRRSV remains a critical challenge for swine health management. Immunosensors are feasible diagnostic alternatives, where antigen–antibody interactions can be immediately quantitatively determined. Electrochemical sensor operation is based on changes in interfacial electron transfer at the working electrode surface, which are monitored using electrochemical impedance spectroscopy (EIS). In this approach, a redox probe ([Fe(CN)6]3−/[Fe(CN)6]4−) is used to evaluate the charge-transfer resistance (Rct) at the electrode interface. Variations in analyte concentration lead to changes in the interfacial properties of the electrode, particularly after biomolecular interactions such as antibody binding. These interactions hinder electron transfer, resulting in an increase in Rct. The analytical signal is therefore based on the correlation between the change in Rct (ΔRct) and the concentration of the target analyte, enabling quantitative analysis through calibration plots. The goal was the establishment of a peptide based electrochemical immunosensor for quantifying antibodies against PRRSV. Gold electrode functionalization was characterized using EIS, the GP5-B peptide, and casein protein. Balb/c mice were immunized according to control, BSA-immunized, and GP5-B peptide-immunized groups. Control pigs were free from the porcine respiratory disease complex (PRDC) and nonvaccinated. Vaccinated pigs were injected using commercial Ingelvac vaccine according to the manufacturer's instructions, and naturally infected pigs were also included in the study. Antibodies were measured using ELISA assays and an immunosensor. The immunosensor recognized antigen–antibody interactions, with a limit of detection (LOD) of 6 ng mL−1, a repeatability of intra-assay CV of 5.05%, and a reproducibility inter-assay CV of 4.08% through batch to batch. Additionally, it achieved a sensitivity of 100%, and a specificity of at least 93%. Considering all the data, compared to immunoglobulin G detection via ELISAs, the proposed peptide-based electrochemical immunosensor is valuable for detecting antibodies against PRRSV. These results suggest the feasibility of biosensors for serological diagnosis in pigs.
- 8 May 2026
- Published by Royal Society of Chemistry (RSC) in Sensors & Diagnostics
- Vol. 5 (6) , 858-867
Open AccessEstablishment of a peptide-based electrochemical immunosensor for detecting antibodies against the GP5 protein from the porcine reproductive and respiratory syndrome virus
Porcine reproductive and respiratory syndrome (PRRS) is one of the most economically devastating diseases that affect the swine industry worldwide. Although enzyme-linked immunosorbent assays (ELISAs) are the gold standard for analyzing antibodies against viruses, they have some limitations, such as sample transport and analysis times and cost. Rapid serological surveillance of PRRSV remains a critical challenge for swine health management. Immunosensors are feasible diagnostic alternatives, where antigen–antibody interactions can be immediately quantitatively determined. Electrochemical sensor operation is based on changes in interfacial electron transfer at the working electrode surface, which are monitored using electrochemical impedance spectroscopy (EIS). In this approach, a redox probe ([Fe(CN)6]3−/[Fe(CN)6]4−) is used to evaluate the charge-transfer resistance (Rct) at the electrode interface. Variations in analyte concentration lead to changes in the interfacial properties of the electrode, particularly after biomolecular interactions such as antibody binding. These interactions hinder electron transfer, resulting in an increase in Rct. The analytical signal is therefore based on the correlation between the change in Rct (ΔRct) and the concentration of the target analyte, enabling quantitative analysis through calibration plots. The goal was the establishment of a peptide based electrochemical immunosensor for quantifying antibodies against PRRSV. Gold electrode functionalization was characterized using EIS, the GP5-B peptide, and casein protein. Balb/c mice were immunized according to control, BSA-immunized, and GP5-B peptide-immunized groups. Control pigs were free from the porcine respiratory disease complex (PRDC) and nonvaccinated. Vaccinated pigs were injected using commercial Ingelvac vaccine according to the manufacturer's instructions, and naturally infected pigs were also included in the study. Antibodies were measured using ELISA assays and an immunosensor. The immunosensor recognized antigen–antibody interactions, with a limit of detection (LOD) of 6 ng mL−1, a repeatability of intra-assay CV of 5.05%, and a reproducibility inter-assay CV of 4.08% through batch to batch. Additionally, it achieved a sensitivity of 100%, and a specificity of at least 93%. Considering all the data, compared to immunoglobulin G detection via ELISAs, the proposed peptide-based electrochemical immunosensor is valuable for detecting antibodies against PRRSV. These results suggest the feasibility of biosensors for serological diagnosis in pigs.
- Open Access
Synthetic Peptides Elicit Humoral Response against Porcine Reproductive and Respiratory Syndrome Virus in Swine
The aim of this study was to analyze the immunogenic response elicited in swine by two synthetic peptides derived from GP5 to understand the role of lineal B epitopes in the humoral and B-cell-mediated response against the porcine reproductive and respiratory syndrome virus (PRRSV). For inoculation, twenty-one-day-old pigs were allocated into six groups: control, vehicle, vaccinated (Ingelvac-PRRSV, MLV®), non-vaccinated and naturally infected, GP5-B and GP5-B3. At 2 days post-immunization (dpi), the GP5-B3 peptide increased the serum concentrations of cytokines associated with activate adaptive cellular immunity, IL-1β (1.15 ± 1.15 to 10.17 ± 0.94 pg/mL) and IL-12 (323.8 ± 23.3 to 778.5 ± 58.11 pg/mL), compared to the control group. The concentration of IgGs anti-GP5-B increased in both cases at 21 and 42 dpi compared to that at 0 days (128.3 ± 8.34 ng/mL to 231.9 ± 17.82 and 331 ± 14.86 ng/mL), while IgGs anti-GP5-B3 increased at 21 dpi (105.1 ± 19.06 to 178 ± 15.09 ng/mL) and remained at the same level until 42 dpi. Also, antibody-forming/Plasma B cells (CD2+/CD21−) increased in both cases (9.85 ± 0.7% to 13.67 ± 0.44 for GP5-B and 15.72 ± 1.27% for GP5-B3). Furthermore, primed B cells (CD2−/CD21+) from immunized pigs showed an increase in both cases (9.62 ± 1.5% to 24.51 ± 1.3 for GP5-B and 34 ± 2.39% for GP5-B3) at 42 dpi. Conversely the naïve B cells from immunized pigs decreased compared with the control group (8.84 ± 0.63% to 6.25 ± 0.66 for GP5-B and 5.78 ± 0.48% for GP5-B3). Importantly, both GP5-B and GP5-B3 peptides exhibited immunoreactivity against serum antibodies from the vaccinated group, as well as the non-vaccinated and naturally infected group. In conclusion, GP5-B and GP5-B3 peptides elicited immunogenicity mediated by antigen-specific IgGs and B cell activation.
Open AccessSynthetic Peptides Elicit Humoral Response against Porcine Reproductive and Respiratory Syndrome Virus in Swine
The aim of this study was to analyze the immunogenic response elicited in swine by two synthetic peptides derived from GP5 to understand the role of lineal B epitopes in the humoral and B-cell-mediated response against the porcine reproductive and respiratory syndrome virus (PRRSV). For inoculation, twenty-one-day-old pigs were allocated into six groups: control, vehicle, vaccinated (Ingelvac-PRRSV, MLV®), non-vaccinated and naturally infected, GP5-B and GP5-B3. At 2 days post-immunization (dpi), the GP5-B3 peptide increased the serum concentrations of cytokines associated with activate adaptive cellular immunity, IL-1β (1.15 ± 1.15 to 10.17 ± 0.94 pg/mL) and IL-12 (323.8 ± 23.3 to 778.5 ± 58.11 pg/mL), compared to the control group. The concentration of IgGs anti-GP5-B increased in both cases at 21 and 42 dpi compared to that at 0 days (128.3 ± 8.34 ng/mL to 231.9 ± 17.82 and 331 ± 14.86 ng/mL), while IgGs anti-GP5-B3 increased at 21 dpi (105.1 ± 19.06 to 178 ± 15.09 ng/mL) and remained at the same level until 42 dpi. Also, antibody-forming/Plasma B cells (CD2+/CD21−) increased in both cases (9.85 ± 0.7% to 13.67 ± 0.44 for GP5-B and 15.72 ± 1.27% for GP5-B3). Furthermore, primed B cells (CD2−/CD21+) from immunized pigs showed an increase in both cases (9.62 ± 1.5% to 24.51 ± 1.3 for GP5-B and 34 ± 2.39% for GP5-B3) at 42 dpi. Conversely the naïve B cells from immunized pigs decreased compared with the control group (8.84 ± 0.63% to 6.25 ± 0.66 for GP5-B and 5.78 ± 0.48% for GP5-B3). Importantly, both GP5-B and GP5-B3 peptides exhibited immunoreactivity against serum antibodies from the vaccinated group, as well as the non-vaccinated and naturally infected group. In conclusion, GP5-B and GP5-B3 peptides elicited immunogenicity mediated by antigen-specific IgGs and B cell activation.
- Open Access
- 13 May 2024
- Published by MDPI AG in Preprints.org
Induction of Specific IgG antibodies and B-Cell Mediated Immunity by Glycoprotein 5 Peptides in Porcine Reproductive and Respiratory Syndrome virus Infected Swine
We analyze the humoral and B-cell mediated immunogenic response induced by GP5 lineal epitopes from porcine reproductive and respiratory syndrome virus (PRRSV) to explore the role of this protein in the protective response. For inoculation, pigs aged twenty-one days were allocated into six groups (seven pigs per group): control (PBS), vehicle (carrier), vaccinated (Ingelvac-PRRSV, MLV®), non-vaccinated and naturally infected, GP5-B and GP5-B3. Subsequently blood samples were collected and analyzed. Cytokine were measured by ProcartaPlex kit. Peptide-specific IgGs and cross-reactivity against peptides were analyzed by ELISA and B-cell subpopulations were analyzed by flow cytometry. At 2 days post-immunization (dpi), the GP5-B3 peptide increased the serum concentrations of cytokines associated to activate adaptive cellular immunity (IL-1β and IL-12). The concentration of IgGs anti-GP5-B increased in both cases at 21 and 42 dpi, while IgGs anti-GP5-B3 increased at 21 dpi and remained at the same level until 42 dpi. Also, antibody-forming/Plasma B cells (CD2+/CD21-) and primed B cells (CD2-/CD21+) from immunized pigs showed an increase at 42 dpi. Conversely the naïve B cells from immunized pigs decreased compared with the controls. Importantly, Both GP5-B and GP5-B3 peptides exhibited immunoreactivity against serum antibodies from vaccinated group, as well as non-vaccinated and naturally infected group. In conclusion, GP5-B and GP5-B3 peptides elicited immunogenicity mediated by antigen specific IgG´s and B-cell activation.
- 13 May 2024
- Published by MDPI AG in Preprints.org
Open AccessInduction of Specific IgG antibodies and B-Cell Mediated Immunity by Glycoprotein 5 Peptides in Porcine Reproductive and Respiratory Syndrome virus Infected Swine
We analyze the humoral and B-cell mediated immunogenic response induced by GP5 lineal epitopes from porcine reproductive and respiratory syndrome virus (PRRSV) to explore the role of this protein in the protective response. For inoculation, pigs aged twenty-one days were allocated into six groups (seven pigs per group): control (PBS), vehicle (carrier), vaccinated (Ingelvac-PRRSV, MLV®), non-vaccinated and naturally infected, GP5-B and GP5-B3. Subsequently blood samples were collected and analyzed. Cytokine were measured by ProcartaPlex kit. Peptide-specific IgGs and cross-reactivity against peptides were analyzed by ELISA and B-cell subpopulations were analyzed by flow cytometry. At 2 days post-immunization (dpi), the GP5-B3 peptide increased the serum concentrations of cytokines associated to activate adaptive cellular immunity (IL-1β and IL-12). The concentration of IgGs anti-GP5-B increased in both cases at 21 and 42 dpi, while IgGs anti-GP5-B3 increased at 21 dpi and remained at the same level until 42 dpi. Also, antibody-forming/Plasma B cells (CD2+/CD21-) and primed B cells (CD2-/CD21+) from immunized pigs showed an increase at 42 dpi. Conversely the naïve B cells from immunized pigs decreased compared with the controls. Importantly, Both GP5-B and GP5-B3 peptides exhibited immunoreactivity against serum antibodies from vaccinated group, as well as non-vaccinated and naturally infected group. In conclusion, GP5-B and GP5-B3 peptides elicited immunogenicity mediated by antigen specific IgG´s and B-cell activation.
- Open Access
Expression of Basement Membrane Molecules by Wharton Jelly Stem Cells (WJSC) in Full-Term Human Umbilical Cords, Cell Cultures and Microtissues
Wharton’s jelly stem cells (WJSC) from the human umbilical cord (UC) are one of the most promising mesenchymal stem cells (MSC) in tissue engineering (TE) and advanced therapies. The cell niche is a key element for both, MSC and fully differentiated tissues, to preserve their unique features. The basement membrane (BM) is an essential structure during embryonic development and in adult tissues. Epithelial BMs are well-known, but similar structures are present in other histological structures, such as in peripheral nerve fibers, myocytes or chondrocytes. Previous studies suggest the expression of some BM molecules within the Wharton’s Jelly (WJ) of UC, but the distribution pattern and full expression profile of these molecules have not been yet elucidated. In this sense, the aim of this histological study was to evaluate the expression of main BM molecules within the WJ, cultured WJSC and during WJSC microtissue (WJSC-MT) formation process. Results confirmed the presence of a pericellular matrix composed by the main BM molecules—collagens (IV, VII), HSPG2, agrin, laminin and nidogen—around the WJSC within UC. Additionally, ex vivo studies demonstrated the synthesis of these BM molecules, except agrin, especially during WJSC-MT formation process. The WJSC capability to synthesize main BM molecules could offer new alternatives for the generation of biomimetic-engineered substitutes where these molecules are particularly needed.
Open AccessExpression of Basement Membrane Molecules by Wharton Jelly Stem Cells (WJSC) in Full-Term Human Umbilical Cords, Cell Cultures and Microtissues
Wharton’s jelly stem cells (WJSC) from the human umbilical cord (UC) are one of the most promising mesenchymal stem cells (MSC) in tissue engineering (TE) and advanced therapies. The cell niche is a key element for both, MSC and fully differentiated tissues, to preserve their unique features. The basement membrane (BM) is an essential structure during embryonic development and in adult tissues. Epithelial BMs are well-known, but similar structures are present in other histological structures, such as in peripheral nerve fibers, myocytes or chondrocytes. Previous studies suggest the expression of some BM molecules within the Wharton’s Jelly (WJ) of UC, but the distribution pattern and full expression profile of these molecules have not been yet elucidated. In this sense, the aim of this histological study was to evaluate the expression of main BM molecules within the WJ, cultured WJSC and during WJSC microtissue (WJSC-MT) formation process. Results confirmed the presence of a pericellular matrix composed by the main BM molecules—collagens (IV, VII), HSPG2, agrin, laminin and nidogen—around the WJSC within UC. Additionally, ex vivo studies demonstrated the synthesis of these BM molecules, except agrin, especially during WJSC-MT formation process. The WJSC capability to synthesize main BM molecules could offer new alternatives for the generation of biomimetic-engineered substitutes where these molecules are particularly needed.
- Open Access
- 12 March 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (3) , 292
Ex Vivo Generation and Characterization of Human Hyaline and Elastic Cartilaginous Microtissues for Tissue Engineering Applications
Considering the high prevalence of cartilage-associated pathologies, low self-repair capacity and limitations of current repair techniques, tissue engineering (TE) strategies have emerged as a promising alternative in this field. Three-dimensional culture techniques have gained attention in recent years, showing their ability to provide the most biomimetic environment for the cells under culture conditions, enabling the cells to fabricate natural, 3D functional microtissues (MTs). In this sense, the aim of this study was to generate, characterize and compare scaffold-free human hyaline and elastic cartilage-derived MTs (HC-MTs and EC-MTs, respectively) under expansion (EM) and chondrogenic media (CM). MTs were generated by using agarose microchips and evaluated ex vivo for 28 days. The MTs generated were subjected to morphometric assessment and cell viability, metabolic activity and histological analyses. Results suggest that the use of CM improves the biomimicry of the MTs obtained in terms of morphology, viability and extracellular matrix (ECM) synthesis with respect to the use of EM. Moreover, the overall results indicate a faster and more sensitive response of the EC-derived cells to the use of CM as compared to HC chondrocytes. Finally, future preclinical in vivo studies are still needed to determine the potential clinical usefulness of these novel advanced therapy products.
- 12 March 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (3) , 292
Open AccessEx Vivo Generation and Characterization of Human Hyaline and Elastic Cartilaginous Microtissues for Tissue Engineering Applications
Considering the high prevalence of cartilage-associated pathologies, low self-repair capacity and limitations of current repair techniques, tissue engineering (TE) strategies have emerged as a promising alternative in this field. Three-dimensional culture techniques have gained attention in recent years, showing their ability to provide the most biomimetic environment for the cells under culture conditions, enabling the cells to fabricate natural, 3D functional microtissues (MTs). In this sense, the aim of this study was to generate, characterize and compare scaffold-free human hyaline and elastic cartilage-derived MTs (HC-MTs and EC-MTs, respectively) under expansion (EM) and chondrogenic media (CM). MTs were generated by using agarose microchips and evaluated ex vivo for 28 days. The MTs generated were subjected to morphometric assessment and cell viability, metabolic activity and histological analyses. Results suggest that the use of CM improves the biomimicry of the MTs obtained in terms of morphology, viability and extracellular matrix (ECM) synthesis with respect to the use of EM. Moreover, the overall results indicate a faster and more sensitive response of the EC-derived cells to the use of CM as compared to HC chondrocytes. Finally, future preclinical in vivo studies are still needed to determine the potential clinical usefulness of these novel advanced therapy products.
- 15 April 2020
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 14 (6) , 789-806
Detergent‐based decellularized peripheral nerve allografts: An in vivo preclinical study in the rat sciatic nerve injury model
Nerve autograft is the gold standard technique to repair critical nerve defects, but efficient alternatives are needed. The present study evaluated the suitability of our novel Roosens‐based (RSN) decellularized peripheral nerve allografts (DPNAs) in the repair of 10‐mm sciatic nerve defect in rats at the functional and histological levels after 12‐weeks. These DPNAs were compared to the autograft technique (AUTO), and Sondell (SD) or Hudson (HD) based DPNAs. Clinical and functional assessments demonstrated a partial regeneration in all operated animals. RSN‐based DPNAs results were comparable with SD and HD groups, and closely comparable to the AUTO group without significant differences (p>0.05). Overall hematological studies confirmed the biocompatibility of grafted DPNAs. In addition, biochemistry revealed some signs of muscle affection in all operated animals. These results were confirmed by the loss of weight and volume of the muscle, and by muscle histology, especially in DPNAs. Histology of repaired nerves confirmed an active nerve tissue regeneration and partial myelination along with the implanted grafts, being the results obtained with HD and RSN‐based DPNAs comparable to the AUTO group. Finally, this in vivo study suggests that our novel RSN‐based DPNAs supported a comparable tissue regeneration, along the 10‐mm nerve gap, after 12 weeks follow‐up to HD DPNAs and both were superior to SD group and closely comparable to autograft technique. However, further improvements are needed to overcome the efficacy of the nerve autograft technique.
- 15 April 2020
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 14 (6) , 789-806
Detergent‐based decellularized peripheral nerve allografts: An in vivo preclinical study in the rat sciatic nerve injury model
Nerve autograft is the gold standard technique to repair critical nerve defects, but efficient alternatives are needed. The present study evaluated the suitability of our novel Roosens‐based (RSN) decellularized peripheral nerve allografts (DPNAs) in the repair of 10‐mm sciatic nerve defect in rats at the functional and histological levels after 12‐weeks. These DPNAs were compared to the autograft technique (AUTO), and Sondell (SD) or Hudson (HD) based DPNAs. Clinical and functional assessments demonstrated a partial regeneration in all operated animals. RSN‐based DPNAs results were comparable with SD and HD groups, and closely comparable to the AUTO group without significant differences (p>0.05). Overall hematological studies confirmed the biocompatibility of grafted DPNAs. In addition, biochemistry revealed some signs of muscle affection in all operated animals. These results were confirmed by the loss of weight and volume of the muscle, and by muscle histology, especially in DPNAs. Histology of repaired nerves confirmed an active nerve tissue regeneration and partial myelination along with the implanted grafts, being the results obtained with HD and RSN‐based DPNAs comparable to the AUTO group. Finally, this in vivo study suggests that our novel RSN‐based DPNAs supported a comparable tissue regeneration, along the 10‐mm nerve gap, after 12 weeks follow‐up to HD DPNAs and both were superior to SD group and closely comparable to autograft technique. However, further improvements are needed to overcome the efficacy of the nerve autograft technique.
- 1 April 2020
- Published by Elsevier in Journal of the Mechanical Behavior of Biomedical Materials
- Vol. 104, 103619
In vitro characterization of a novel magnetic fibrin-agarose hydrogel for cartilage tissue engineering
- 1 April 2020
- Published by Elsevier in Journal of the Mechanical Behavior of Biomedical Materials
- Vol. 104, 103619
In vitro characterization of a novel magnetic fibrin-agarose hydrogel for cartilage tissue engineering
- 8 November 2019
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 21 (4) , 378-386
Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype–phenotype correlation study
Aims: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a life-threatening entity with a highly heterogeneous genetic background. Cardiac magnetic resonance (CMR) imaging can identify fibrofatty scar by late gadolinium enhancement (LGE). Our aim is to investigate genotype–phenotype correlation in ARVC/D mutation carriers, focusing on CMR-LGE and myocardial fibrosis patterns. Methods and results: A cohort of 44 genotyped patients, 33 with definite and 11 with borderline ARVC/D diagnosis, was characterized using CMR and divided into groups according to their genetic condition (desmosomal, non-desmosomal mutation, or negative). We collected information on cardiac volumes and function, as well as LGE pattern and extension. In addition, available ventricular myocardium samples from patients with pathogenic gene mutations were histopathologically analysed. Half of the patients were women, with a mean age of 41.6 ± 17.5 years. Next-generation sequencing identified a potential pathogenic mutation in 71.4% of the probands. The phenotype varied according to genetic status, with non-desmosomal male patients showing lower left ventricular (LV) systolic function. LV fibrosis was similar between groups, but distribution in non-desmosomal patients was frequently located at the posterolateral LV wall; a characteristic LV subepicardial circumferential LGE pattern was significantly associated with ARVC/D caused by desmin mutation. Histological analysis showed increased fibrillar connective tissue and intercellular space in all the samples. Conclusion: Desmosomal and non-desmosomal mutation carriers showed different morphofunctional features but similar LV LGE presence. DES mutation carriers can be identified by a specific and extensive LV subepicardial circumferential LGE pattern. Further studies should investigate the specificity of LGE in ARVC/D.
- 8 November 2019
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 21 (4) , 378-386
Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype–phenotype correlation study
Aims: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a life-threatening entity with a highly heterogeneous genetic background. Cardiac magnetic resonance (CMR) imaging can identify fibrofatty scar by late gadolinium enhancement (LGE). Our aim is to investigate genotype–phenotype correlation in ARVC/D mutation carriers, focusing on CMR-LGE and myocardial fibrosis patterns. Methods and results: A cohort of 44 genotyped patients, 33 with definite and 11 with borderline ARVC/D diagnosis, was characterized using CMR and divided into groups according to their genetic condition (desmosomal, non-desmosomal mutation, or negative). We collected information on cardiac volumes and function, as well as LGE pattern and extension. In addition, available ventricular myocardium samples from patients with pathogenic gene mutations were histopathologically analysed. Half of the patients were women, with a mean age of 41.6 ± 17.5 years. Next-generation sequencing identified a potential pathogenic mutation in 71.4% of the probands. The phenotype varied according to genetic status, with non-desmosomal male patients showing lower left ventricular (LV) systolic function. LV fibrosis was similar between groups, but distribution in non-desmosomal patients was frequently located at the posterolateral LV wall; a characteristic LV subepicardial circumferential LGE pattern was significantly associated with ARVC/D caused by desmin mutation. Histological analysis showed increased fibrillar connective tissue and intercellular space in all the samples. Conclusion: Desmosomal and non-desmosomal mutation carriers showed different morphofunctional features but similar LV LGE presence. DES mutation carriers can be identified by a specific and extensive LV subepicardial circumferential LGE pattern. Further studies should investigate the specificity of LGE in ARVC/D.
- 1 September 2019
- Published by Elsevier in Experimental Eye Research
- Vol. 186, 107717
Scleral surgical repair through the use of nanostructured fibrin/agarose-based films in rabbits
- 1 September 2019
- Published by Elsevier in Experimental Eye Research
- Vol. 186, 107717
Scleral surgical repair through the use of nanostructured fibrin/agarose-based films in rabbits
- Open Access
- 29 March 2019
- Published by Forum Multimedia Publishing LLC in European Cells and Materials
- Vol. 37, 233-249
Effective use of mesenchymal stem cells in human skin substitutes generated by tissue engineering
Mesenchymal stem cells (MSCs) can differentiate toward epithelial cells and may be used as an alternative source for generation of heterotypical artificial human skin substitutes, thus, enhancing their development and translation potential to the clinic. The present study aimed at comparing four types of heterotypical human bioengineered skin generated using MSCs as an alternative epithelial cell source. Adipose-tissue-derived stem cells (ADSCs), dental pulp stem cells (DPSCs), Wharton's jelly stem cells (WJSCs) and bone marrow stem cells (BMSCs) were used for epidermal regeneration on top of dermal skin substitutes. Heterotypic human skin substitutes were evaluated before and after implantation in immune-deficient athymic mice for 30 d. Histological and genetic studies were performed to evaluate extracellular matrix synthesis, epidermal differentiation and human leukocyte antigen (HLA) molecule expression. The four cell types differentiated into keratinocytes, as shown by the expression of cytokeratin 10 and filaggrin 30 d post-grafting; also, they induced dermal fibroblasts responsible for the synthesis of extracellular fibrillar and non-fibrillar components, in a similar way among each other. WJSCs and BMSCs showed higher expression of cytokeratin 10 and filaggrin, suggesting these cells were more prone to epidermal regeneration. The absence of HLA molecules, even when the epithelial layer was differentiated, supports the future clinical use of these substitutes - especially ADSCs, DPSCs and WJSCs - with low rejection risk. MSCs allowed the generation of bioengineered human skin substitutes with potential clinical usefulness. According to their epidermal differentiation potential and lack of HLA antigens, WJSCs should preferentially be used.
- 29 March 2019
- Published by Forum Multimedia Publishing LLC in European Cells and Materials
- Vol. 37, 233-249
Open AccessEffective use of mesenchymal stem cells in human skin substitutes generated by tissue engineering
Mesenchymal stem cells (MSCs) can differentiate toward epithelial cells and may be used as an alternative source for generation of heterotypical artificial human skin substitutes, thus, enhancing their development and translation potential to the clinic. The present study aimed at comparing four types of heterotypical human bioengineered skin generated using MSCs as an alternative epithelial cell source. Adipose-tissue-derived stem cells (ADSCs), dental pulp stem cells (DPSCs), Wharton's jelly stem cells (WJSCs) and bone marrow stem cells (BMSCs) were used for epidermal regeneration on top of dermal skin substitutes. Heterotypic human skin substitutes were evaluated before and after implantation in immune-deficient athymic mice for 30 d. Histological and genetic studies were performed to evaluate extracellular matrix synthesis, epidermal differentiation and human leukocyte antigen (HLA) molecule expression. The four cell types differentiated into keratinocytes, as shown by the expression of cytokeratin 10 and filaggrin 30 d post-grafting; also, they induced dermal fibroblasts responsible for the synthesis of extracellular fibrillar and non-fibrillar components, in a similar way among each other. WJSCs and BMSCs showed higher expression of cytokeratin 10 and filaggrin, suggesting these cells were more prone to epidermal regeneration. The absence of HLA molecules, even when the epithelial layer was differentiated, supports the future clinical use of these substitutes - especially ADSCs, DPSCs and WJSCs - with low rejection risk. MSCs allowed the generation of bioengineered human skin substitutes with potential clinical usefulness. According to their epidermal differentiation potential and lack of HLA antigens, WJSCs should preferentially be used.